Duchenne Muscular Dystrophy

Latest News

Ifetroban may improve LVEF in patients with DMD. - REDPIXEL - stock.adobe.com
Ifetroban Improves Heart Function in DMD

February 7th 2025

There is an unmet need for therapies targeting Duchenne muscular dystrophy (DMD)–related heart disease, and phase 2 results suggest ifetroban may improve left ventricular ejection fraction in patients with DMD.

Duchenne muscular dystrophy | Image credit: hafakot - stock.adobe.com
EMBARK 2: Delandistrogene Moxeparvovec Shows Sustained Benefits in DMD

January 28th 2025

Heart and stethoscope | Image credit: inthasone - stock.adobe.com
Prophylactic Cardiac Medication May Prolong Survival in DMD

January 24th 2025

AJMC
Quantifying the Altruism Value for a Rare Pediatric Disease: Duchenne Muscular Dystrophy

January 14th 2025

Past studies have explored the association between motor and cardiac function in younger patients with DMD, but there is a lack of research on this relationship as patients with DMD age. | Image credit: Nana_studio - stock.adobe.com
Later Loss of Ambulation Linked With Better Heart Health in DMD

January 13th 2025

More News

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo